National Science Foundation (NSF)
- This topic has 56 replies, 24 voices, and was last updated 2 years, 2 months ago by
.
-
Posts
-
I have two questions about NSF:
My general view was that SBIR grants from NSF vs NIH were typically smaller dollar amounts for both phase I and phase 2 but I don’t have a rough idea of the size differential. 3x smaller?
My general view was that NSF covered all areas of science but medical. E.g. it could be material sciences, physical sciences, etc. NIH would be the biomedical including pharma, med device, etc. Could you clarify my thinking?
Hello! Thank you for posting your questions.
1) For NSF, the Phase I SBIR budget cap is $256,000 for Phase I and $1,000,000 for Phase II. These are hard caps, and NSF does not offer budget waivers (as is the case for NIH).
For NIH, the Phase I SBIR budget cap is $256,580 for Phase I and $1,710,531 for Phase II. However, NIH applicants may be eligible for additional funding if their project aligns with a published budget waiver topic. Refer to this document for Institute-specific information on budget waiver limits. The budget waiver topics are included in the appendix, or can be viewed separately here. We recommend conferring with an NIH Program Officer to confirm whether your project aligns with a budget waiver topic.2) Both NSF and NIH fund biomedical/health projects through the SBIR program, but NSF does not support drug development and they generally do not support clinical trials, clinical validation of information technologies or medical devices, or studies performed primarily for regulatory purposes. Limited studies with human subjects may be acceptable to the extent that they are performed with the goal of establishing feasibility of early-stage technologies. If you have difficulty determining whether your technology aligns best with NIH or NSF, we recommend reaching out to a Program Officer/Director to discuss your technology and scope of work.
Please feel free to reach out if you’d like additional clarification!
Hi M!
To your first question: results are starting to come in, but the exact time depends on your NSF topic and the scheduled date of the review session hosted by the NSF Program Director overseeing your topic.
As to your second question, this is difficult to answer because of the large amount of variables. E.g. are the changes minor, or would they require some additional research to be completed? Can the proposal in its essence be resubmitted, or does it require a fundamental reorientation of the priorities? Regardless, with NSF moving to submission windows rather than hard submission dates, you can make sure your proposal is in optimal shape to be submitted, avoiding the need for a last-minute scramble to submit.
Let us know if you have any other questions!
Best,
WoutHi Shoba,
The NSF permits foreign collaborators or CROs provided that support is only requested for the US portion of the collaborative effort. NSF may however consider cases where the foreign collaborator provides a unique and essential capability that is not available in the US. You can see NSF’s policy on Foreign Organizations here.
EGC is planning to publish a book for preparing NSF grants. We are anticipating that it will be released in Q1 2021 and available on Amazon.
Best,
NiteshHi!
NSF anticipates on releasing their new SBIR/STTR solicitation within the next few weeks. The project pitch mechanism is currently available, so you can already submit your pitch and – upon acceptance – start working on your full proposal while awaiting the new solicitation to be released.
Best,
WoutHi!
NSF just announced that the next submission due date is March 4th, 2021:
https://www.nsf.gov/funding/pgm_list.jsp?sel_org=ENG&status=1&ord=nsf_num_desc&org=NSF&showItems=50Best,
Lu
- You must be logged in to reply to this topic.